Abstract:1. trans-Resveratrol (resveratrol) has been shown to have beneficial effects on the cardiovascular system in a number of studies. It is, however, unclear whether this naturally occurring compound can protect against cardiac hypertrophy. The aim of the present study was to investigate the effects of resveratrol on cardiac hypertrophy in vivo and the potential underlying mechanisms involving endothelin (ET), angiotensin (Ang) II and nitric oxide (NO) in partially nephrectomized rats.2. Animal models bearing cardiac hypertrophy were replicated in male Sprague-Dawley rats following partial nephrectomy (PNX). Resveratrol (10 or 50 mg/kg) was administered to rats by gavage for 4 weeks. Simultaneous PNX and sham operation controls were simultaneously established in the present study. The systolic blood pressure (SBP) of rats was measured at baseline and, along with heart weight, after 4 weeks treatment. Serum ET-1, AngII and NO concentrations were determined.3. In the present study, it was shown that, compared with rats in the sham-operated group, rats in the PNX group had significantly higher SBP (154.1 +/- 22.7 mmHg), heart weight (1.69 +/- 0.24 g) and serum ET-1 (125.70 +/- 26.27 pg/mL) and AngII serum concentrations (743.63 +/- 86.50 pg/mL), whereas serum NO concentrations were lower (21.1 +/- 6.9 mu mol/L; all P < 0.05). These values in the sham control group were 114 +/- 10 mmHg, 1.28 +/- 0.13 g, 52.44 +/- 21.85 pg/mL, 528.7 +/- 158.5 pg/mL and 53.21 +/- 23.87 mu mol/L, respectively. After 4 weeks treatment with 50 mg/kg resveratrol, SBP, heart,weight and ET-1 and AngII concentrations had decreased to 135.4 +/- 15.8 mmHg, 1.39 +/- 0.15 g, 97.11 +/- 26.74 pg/mL and 629.64 +/- 116.18 pg/mL, respectively. However, the serum NO concentration had increased to 40.1 +/- 14.6 mu mol/L. These values were significantly different from those obtained for the PNX group.4. In conclusion, trans-resveratrol appears to be able to protect against the increase in SBP and subsequent cardiac hypertrophy in vivo and the mechanisms responsible may involve, at least in part, modulation of NO, AngII and ET-1 production.

Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.

Inhibitory effect of resveratrol on cardiac fibroblast proliferation induced by angiotensin II]

[Inhibitory effects of emodin on proliferation of rat vascular smooth muscle cell induced by angiotensin II].

Resveratrol Inhibits High Glucose Induced Collagen Upregulation in Cardiac Fibroblasts Through Regulating TGF-β1-Smad3 Signaling Pathway.

Inhibitory effects of emodin on the proliferation of cultured rat vascular smooth muscle cell-induced by angiotensin II.

Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts.

Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling

[Resveratrol Inhibits Hypoxia-Induced Oxidative Stress and Proliferation in Pulmonary Artery Smooth Muscle Cells Through the HIF-1α/NOX4/ROS Signaling Pathway].

Resveratrol inhibits the expression of typeⅠ and type Ⅲ collagen induced by AngⅡ in cardiac fibroblasts through regulating the TGF-β1/Smad3 signaling pathway

Effects Of Trans-Resveratrol On Hypertension-Induced Cardiac Hypertrophy Using The Partially Nephrectomized Rat Model

Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.

Resveratrol prevents pathological but not physiological cardiac hypertrophy

Resveratrol modulates signalling to inhibit vascular smooth muscle cell proliferation induced by angiotensin II and high glucose

Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes

Resveratrol Inhibits Apoptosis of Hypoxia /Reoxygen-Induced Apoptosis of Cardiac Microvascular Endothelial Cells in Rats

Resveratrol prevented experimental pulmonary vascular remodeling via miR-638 regulating NR4A3/cyclin D1 pathway

Ginsenoside Rb-3 Inhibits Angiotensin Ii-Induced Vascular Smooth Muscle Cells Proliferation

Egcg Inhibits Proliferation of Cardiac Fibroblasts in Rats with Cardiac Hypertrophy

Cryptotanshinone attenuates cardiac fibrosis via downregulation of COX-2, NOX-2, and NOX-4

17Β-Estradiol Inhibits Angiotensin II-induced Collagen Synthesis of Cultured Rat Cardiac Fibroblasts Via Modulating Angiotensin II Receptors

Negative Regulation Of Quinone Reductase 2 By Resveratrol In Cultured Vascular Smooth Muscle Cells